Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
agonist, arm, assistance, Biological, building, Capvaxive, CDC, CID, Cipla, Civil, coformulation, compliance, County, curative, degeneration, diabetic, director, DMC, edema, endpoint, entirety, EyeBio, Eyebiotech, fully, futility, highly, inspection, IPR, leakage, Los, macular, malignant, mutual, neovascular, NMPA, official, opevesostat, pathway, pendency, pertaining, pleural, provisional, PTAB, Rebate, registered, Regulation, rendered, repayment, retinal, ship, Steglatro, tetravalent, tulisokibart, unanimously, unblinding, unconditionally, unexercised, unrecognized, vascular, vibostolimab, vision, Zhifei
Removed:
alleging, appealed, Beach, Breakthrough, Centene, closing, coupled, defrauded, denied, direct, Dohme, Eastern, falsifying, Foundation, fraud, Humana, indirect, Insurer, involvement, Kaiser, LLC, making, MDL, misrepresented, moot, moved, MSP, participate, Pennsylvania, proceed, prosecution, pursuing, putative, Rebecca, resolve, retailer, Schering, Sharp, Singapore, Smith, swine, unsealed, violation, Vytorin
Filing tables
Filing exhibits
Related press release
Associated MRK transcripts
MRK similar filings
Filing view
External links
Exhibit 32.2
Section 1350
Certification of Chief Financial Officer
Pursuant to 18 U.S.C. Section 1350, the undersigned officer of Merck & Co., Inc. (the “Company”), hereby certifies that the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: August 5, 2024 | /s/ Caroline Litchfield | |||||||
| Name: Title: | CAROLINE LITCHFIELD Executive Vice President, Chief Financial Officer | |||||||